|
0
|
3
|
1mcsP |
Principles and pitfalls in designing site directed peptide ligands |
|
47
|
222
|
8fabB |
Crystal structure of the fab fragment from the human myeloma immunoglobulin igg hil at 1.8 angstroms resolution |
|
42
|
206
|
8fabA |
Crystal structure of the fab fragment from the human myeloma immunoglobulin igg hil at 1.8 angstroms resolution |
|
56
|
214
|
6fabL |
Three-dimensional structure of murine anti-p-azophenylarsonate fab 36-71. 1. x-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten |
|
44
|
222
|
6fabH |
Three-dimensional structure of murine anti-p-azophenylarsonate fab 36-71. 1. x-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten |
|
44
|
219
|
4fabL |
Three-dimensional structure of a fluorescein-fab complex crystallized in 2-methyl-2,4-pentanediol |
|
38
|
216
|
4fabH |
Three-dimensional structure of a fluorescein-fab complex crystallized in 2-methyl-2,4-pentanediol |
|
45
|
216
|
4bjlA |
Locw, a lambda 1 type light-chain dimer (bence-jones protein) crystallized in distilled water |
|
25
|
117
|
43caB |
Crystallographic structure of the esterolytic and amidolytic 43c9 antibody with bound p-nitrophenol |
|
26
|
113
|
43caA |
Crystallographic structure of the esterolytic and amidolytic 43c9 antibody with bound p-nitrophenol |
|
25
|
118
|
43c9B |
Crystallographic structure of the esterolytic and amidolytic 43c9 antibody |
|
27
|
113
|
43c9A |
Crystallographic structure of the esterolytic and amidolytic 43c9 antibody |
|
37
|
216
|
2mcg1 |
Three-dimensional structure of a light chain dimer crystallized in water. conformational flexibility of a molecule in two crystal forms |
|
25
|
114
|
4lveA |
Len k30t mutant: a domain flip as a result of a single amino acid substitution |
|
34
|
216
|
3mcg1 |
Three-dimensional structure of a light chain dimer crystallized in water. conformational flexibility of a molecule in two crystal forms |
|
27
|
114
|
3lveA |
Len q38e mutant: a domain flip from a single amino acid substitution |
|
41
|
216
|
3bjlA |
Loc, a lambda 1 type light-chain dimer (bence-jones protein) crystallized in ammonium sulfate |
|
27
|
114
|
2rheA |
Structure of a novel bence-jones protein (rhe) fragment at 1.6 angstroms resolution |
|
39
|
216
|
2pcpA |
Antibody fab complexed with phencyclidine |
|
33
|
215
|
2pcpB |
Antibody fab complexed with phencyclidine |
|
27
|
113
|
2lveA |
Recombinant len |
|
14
|
56
|
2j53A |
Solution structure of gb1 domain protein g and low and high pressure. |
|
15
|
56
|
2j52A |
Solution structure of gb1 domain protein g and low and high pressure. |
|
39
|
238
|
2ig2H |
Dir primaerstruktur des kristallisierbaren monoklonalen immunoglobulins igg1 kol. ii. aminosaeuresequenz der l-kette, lambda-typ, subgruppe i (german) |
|
21
|
113
|
2imnA |
Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant |
|
49
|
219
|
2igfL |
Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 angstroms |
|
41
|
221
|
2igfH |
Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 angstroms |
|
22
|
114
|
2immA |
Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant |
|
43
|
216
|
2ig2L |
Dir primaerstruktur des kristallisierbaren monoklonalen immunoglobulins igg1 kol. ii. aminosaeuresequenz der l-kette, lambda-typ, subgruppe i (german) |
|
41
|
219
|
2gfbB |
Crystal structure of a catalytic fab having esterase-like activity |
|
54
|
214
|
2gfbA |
Crystal structure of a catalytic fab having esterase-like activity |
|
51
|
213
|
2fbjL |
Refined crystal structure of the galactan-binding immunoglobulin fab j539 at 1.95-angstroms resolution |
|
45
|
229
|
2fb4H |
Dir primaerstruktur des kristallisierbaren monoklonalen immunoglobulins igg1 kol. ii. aminosaeuresequenz der l-kette, lambda-typ, subgruppe i (german) |
|
47
|
214
|
2f5bL |
Crystal structure of fab' from the hiv-1 neutralizing antibody 2f5 in complex with its gp41 epitope |
|
46
|
216
|
2fb4L |
Dir primaerstruktur des kristallisierbaren monoklonalen immunoglobulins igg1 kol. ii. aminosaeuresequenz der l-kette, lambda-typ, subgruppe i (german) |
|
37
|
220
|
2fbjH |
Refined crystal structure of the galactan-binding immunoglobulin fab j539 at 1.95-angstroms resolution |
|
0
|
7
|
2f5bP |
Crystal structure of fab' from the hiv-1 neutralizing antibody 2f5 in complex with its gp41 epitope |
|
46
|
213
|
2f5aL |
Crystal structure of fab' from the hiv-1 neutralizing antibody 2f5 |
|
45
|
235
|
2f5bH |
Crystal structure of fab' from the hiv-1 neutralizing antibody 2f5 in complex with its gp41 epitope |
|
50
|
214
|
2f19L |
Three-dimensional structure of two crystal forms of fab r19.9, from a monoclonal anti-arsonate antibody |
|
43
|
232
|
2f5aH |
Crystal structure of fab' from the hiv-1 neutralizing antibody 2f5 |
|
40
|
221
|
2f19H |
Three-dimensional structure of two crystal forms of fab r19.9, from a monoclonal anti-arsonate antibody |
|
44
|
216
|
2dblL |
Molecular basis of cross-reactivity and the limits of antibody-antigen complementarity |
|
37
|
219
|
2dblH |
Molecular basis of cross-reactivity and the limits of antibody-antigen complementarity |
|
44
|
219
|
2ck0H |
Anti-anti-idiotypic antibody against human angiotensin ii, complex with a synthetic cyclic peptide |
|
34
|
214
|
2cgrH |
Local and transmitted conformational changes on complexation of an anti-sweetener fab |
|
50
|
219
|
2cgrL |
Local and transmitted conformational changes on complexation of an anti-sweetener fab |
|
49
|
216
|
2ck0L |
Anti-anti-idiotypic antibody against human angiotensin ii, complex with a synthetic cyclic peptide |
|
0
|
11
|
2ck0P |
Anti-anti-idiotypic antibody against human angiotensin ii, complex with a synthetic cyclic peptide |
|
24
|
112
|
2bfvL |
Monoclonal antibody fragment fv4155 from e. coli |
